Pre-Open Stock Movers 12/01: (BB) (MRNA) (KSS) Higher; (FOUR) (NOVA) (ZM) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Shift4 Payments (FOUR) Prices 8M Class A Share Secondary Offering at $55/Sh
December 3, 2020 6:32 AM ESTShift4 Payments, Inc. (NYSE: FOUR), a leading independent provider of integrated payment processing and technology solutions, today announced the pricing of the underwritten public offering of 8,000,000 shares of Shift4s Class A common stock by certain selling stockholders (the Secondary Offering), at a price to... More
RBC Capital Reiterates Outperform Rating on Amazon.com (AMZN) Following Day 1 of All Virtual re:Invent Conference
December 2, 2020 6:50 AM ESTRBC analyst Mark Mahaney has remained positive on the outlook for Amazons (NASDAQ: AMZN) AWS after participating in the 9th annual re:Invent event.
The company remains a clear leader in the Cloud Infrastructure as a Service (IaaS) and Platform as a Service (Paas) market, Mahaney writes in todays research note sent to clients.
Of note is how AWSs rate of growth has accelerated over the yearsit took AWS 123 months to get to $10B in annual revenue, 23 months from $10B to $20B, 13 months from $20B to $30B and 12... More
Intellia Therapeutics (NTLA)Prices 4.795M Share Common Offering at $36.50/Sh
December 2, 2020 6:04 AM ESTIntellia Therapeutics, Inc. (NASDAQ: NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, announced today the pricing of an underwritten public offering of 4,794,521 shares of its common stock at... More
Moderna (MRNA) Extends Decline, Down 14%
December 1, 2020 3:06 PM ESTModerna (NASDAQ: MRNA) Extends Decline, Down 14%
Virgin Galactic Holdings (SPCE) Hits High, Up 10%
December 1, 2020 2:05 PM ESTVirgin Galactic Holdings (NYSE: SPCE) Hits High, Up 10%
Moderna (MRNA) Erases Gain, Down 1.5%
December 1, 2020 12:45 PM ESTModerna (NASDAQ: MRNA) Erases Gain, Down 1.5%
Moderna (MRNA) Quickly Pares Gain, Still Up 4.3%
December 1, 2020 10:36 AM ESTModerna (NASDAQ: MRNA) Quickly Pares Gain, Still Up 4.3%
